6 insiders reported 10 Form 4 transactions for Drugs Made In America Acquisition II Corp. (DMII) over the past 18 months (most recent 2025-10-17). Recent activity: Do Catherine (Director) Buy 100,000 shares, Shulgan Myron W. (Director) Buy 100,000 shares, Drugs Made In America Acquisition II LLC (10% Owner) Sell 8.0M shares, Prasad Sridhar G. (Director) Buy 100,000 shares, Drugs Made In America Acquisition II LLC (10% Owner) Buy 700,000 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-10-17 | Do Catherine | Director | Buy | 100,000 | $0 |
| 2025-10-02 | Shulgan Myron W. | Director | Buy | 100,000 | $0 |
| 2025-10-01 | Drugs Made In America Acquisition II LLC | 10% Owner | Sell | 8.0M | $0 |
| 2025-10-01 | Prasad Sridhar G. | Director | Buy | 100,000 | $0 |
| 2025-10-01 | Drugs Made In America Acquisition II LLC | 10% Owner | Buy | 700,000 | $0 |
| 2025-10-01 | Drugs Made In America Acquisition II LLC | 10% Owner | Sell | 400,000 | $0 |
| 2025-10-01 | Stockwell Lynn | CEO and Exe. Chair of Board | Buy | 700,000 | $0 |
| 2025-10-01 | Stockwell Lynn | CEO and Exe. Chair of Board | Sell | 400,000 | $0 |
| 2025-10-01 | Stockwell Lynn | CEO and Exe. Chair of Board | Sell | 8.0M | $0 |
| 2025-10-01 | Worman Glenn C. | CFO | Buy | 100,000 | $0 |
来源：SEC Form 4 申报文件 · 截至 2025-10-17